ZIMMERMANN MARTINE received a stock award from LIGAND PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/9/2026ACC: 0002001011-26-000101
Director
Since Sep 2023
+3.59K
Net shares
Net buyer
$43.1K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
3.77K acquired · 182.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+836.00
Price / share
—
Trade value
—
% of position
18.8%
6/5/2026
4.44K→5.28K
Common Stock
Direct
Shares
−182.00
Price / share
$237.00
Trade value
$43.13K
% of position
3.4%
6/5/2026
5.28K→5.10K
Total
Net shares
+654.00
Net value
-$43.13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/5/2026 | A · Award | +836.00 | — | — | 18.8% | 4.44K | 5.28K |
| Common Stock Direct | 6/5/2026 | F · Tax Withholding | −182.00 | $237.00 | $43.13K | 3.4% | 5.28K | 5.10K |
| Total | +654.00 | -$43.13K | ||||||
Derivative Transactions1
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
2.94K shares
Shares
+2.94K
Strike price
237.0
Held after
2.94K
Exercisable
—
6/5/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock2.94K shares | 6/5/2026 | A · Award | +2.94K | 237.0 | — | 2.94K |